Taiwan Stock Exchange · Healthcare
Pegavision stock from India: price, numbers and tax
Pegavision (6491) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.
By Paasa · Updated
Pegavision at a glance
- Price
- NT$403.00-NT$8.50 (2.07%)
- Market cap
- NT$30.95B
- Day range
- NT$398.00 – NT$411.50
- P/E
- 16.98
- Dividend yield
- 2.48%
- Volume
- 406.18K
- 1 month
- +9.66%
- 6 months
- +40.42%
- YTD
- +41.40%
- 1 year
- +30.21%
- 5 years
- -21.34%
Pegavision statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | NT$7.0B | NT$6.8B | NT$6.8B | NT$6.3B | NT$5.6B |
| Gross profit | NT$3.5B | NT$3.8B | NT$3.7B | NT$3.3B | NT$3.0B |
| Operating income | NT$1.8B | NT$2.0B | NT$2.0B | NT$1.8B | NT$1.5B |
| Net income | NT$1.6B | NT$1.8B | NT$1.7B | NT$1.5B | NT$1.2B |
| Earnings per share | NT$20.87 | NT$23.46 | NT$22.83 | NT$21.75 | NT$17.61 |
| EBITDA | NT$2.8B | NT$2.9B | NT$3.0B | NT$2.8B | NT$2.1B |
| Total assets | NT$16.2B | NT$14.5B | NT$13.9B | NT$9.6B | NT$8.6B |
| Total debt | NT$1.2B | NT$1.0B | NT$1.5B | NT$1.0B | NT$750.7M |
| Cash and short-term investments | NT$4.5B | NT$4.3B | NT$6.2B | NT$2.5B | NT$1.9B |
| Shareholders' equity | NT$11.6B | NT$11.0B | NT$9.9B | NT$6.4B | NT$5.5B |
| Operating cash flow | NT$2.6B | NT$4.2B | NT$799.5M | NT$2.0B | NT$2.6B |
| Free cash flow | NT$1.1B | NT$747.3M | −NT$484.8M | NT$618.0M | NT$780.3M |
| Capital expenditure | −NT$1.5B | −NT$3.5B | −NT$1.3B | −NT$1.4B | −NT$1.9B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in TWD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Visco Vision | 6782.TW | NT$230.00 | NT$14.49B |
| Formosa Optical Technology | 5312.TWO | $89.30 | $5.36B |
| St.Shine Optical | 1565.TWO | $97.50 | $4.92B |
| ICARES Medicus | 6612.TWO | $71.90 | $3.40B |
| Crystalvue Medical | 6527.TWO | $74.00 | $1.88B |
Peers as grouped by the data provider. This is not an investment recommendation.
Why invest in Pegavision from India
What Pegavision does
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. Pegavision operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
What tax do I pay in India when I sell Pegavision shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the TWD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.